[{"id":"154afa1b-c0be-412f-b05f-4aaae6570e78","acronym":"","url":"https://clinicaltrials.gov/study/NCT04015700","created_at":"2021-01-18T19:43:25.060Z","updated_at":"2024-07-02T16:35:15.562Z","phase":"Phase 1","brief_title":"Neoantigen-based Personalized DNA Vaccine in Patients With Newly Diagnosed, Unmethylated Glioblastoma","source_id_and_acronym":"NCT04015700","lead_sponsor":"Washington University School of Medicine","biomarkers":" IDH1 • IDH2 • MGMT","pipe":" | ","alterations":" IDH2 mutation","tags":["IDH1 • IDH2 • MGMT"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e IDH2 mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e rocakinogene sifuplasmid (INO-9012) • GNOS-PV01 • neoantigen DNA vaccine"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 9","initiation":"Initiation: 07/14/2020","start_date":" 07/14/2020","primary_txt":" Primary completion: 05/13/2022","primary_completion_date":" 05/13/2022","study_txt":" Completion: 12/31/2024","study_completion_date":" 12/31/2024","last_update_posted":"2024-03-08"}]